Invesco Nasdaq Biotechnology ETF (IBBQ) Stock
Diversified fund tracking leading biotechnology and healthcare companies. Here's the price, business snapshot, and what's worth knowing about Invesco Nasdaq Biotechnology ETF in October 2026.
The Invesco Nasdaq Biotechnology ETF (IBBQ) offers investors exposure to companies involved in biotechnology and related healthcare sectors. As an exchange-traded fund, it aims to track the performance of a selected index comprising these firms, providing a diversified entry point into this dynamic industry. With a low expense ratio of 0.19%, it allows for cost-effective investment, though returns are not guaranteed and value can fluctuate significantly due to the volatile nature of biotech developments. The fund launched in June 2021 and holds 256 assets, reflecting a broad range of market capitalisations within the sector. Investors may pay a dividend yield of 0.74%, although distributions can vary. This ETF is suitable for those interested in the long-term potential of healthcare innovation, provided they understand the inherent risks and suitability for their personal circumstances.
About This Stock
INVESCO EXCHANGE TRADED FD TR II INVESCO NASDAQ BIOTECHNOLOGY ETF
IBBQ
Current Price
$34.73
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Ticker
IBBQ
Market Cap
N/A
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Sixth Month Growth Performance
Stock Performance Snapshot
Dividend
INVESCO NASDAQ BIOTECHNOLOGY ETF does not pay a dividend, which may indicate it is reinvesting profits to grow faster. If you invested $1000 you would be paid $0 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Sector Innovation
The biotech industry is central to medical advances, though high volatility means outcomes can vary greatly over time.
Low Cost Access
With an expense ratio of 0.19%, this fund offers relatively affordable entry into a specialised market segment.
Diversified Holdings
Holding 256 companies reduces single-stock risk, though broader sector downturns may still impact performance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
